Not Medicare Enrolled

Dr. Luis Noble, M.D.

Reproductive Endocrinology Physician · El Paso, TX
700 S MESA HILLS DR, El Paso, TX 79912
9158429998
Registered in NPPES since 2006
NPI: 1649367285 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Noble from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Noble? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Noble

Dr. Luis Noble is a reproductive endocrinology physician in El Paso, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Noble received a total of $12,609 from 8 pharmaceutical and/or device companies across 84 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Noble is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $12,609 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,609
Total received (2018-2024)
Avg $1,801/year across 7 years
Top 11% in TX for reproductive endocrinology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
8
Companies
84
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$94
2023
$147
2022
$168
2021
$35
2020
$75
2019
$10,006
2018
$2,084

Payments by company (2024)

Ferring Pharmaceuticals Inc.
$94
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$11,551
Ferring Pharmaceuticals Inc.
$562
TherapeuticsMD, Inc.
$156
ABBVIE INC.
$116
CooperSurgical, Inc.
$98
EMD Serono, Inc.
$73
AbbVie Inc.
$42
Duchesnay USA Incorporated
$11
Top 3 companies account for 97.3% of all-time payments
Associated products mentioned in payments ›
ANNOVERA · BIJUVA · Bonjesta · ENDOMETRIN · Gonal-f · IVF Products · LO LOESTRIN FE · Lupron · MENOPUR · ORIAHNN · ORILISSA · Orilissa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a reproductive endocrinology physician in El Paso?
Compare reproductive endocrinology physicians in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse reproductive endocrinology physicians nearby

Geographic Context

Reproductive endocrinology physicians in nearby ZIP areas
1
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
RIO VISTA BEHAVIORAL HEALTH
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Noble is a reproductive endocrinology physician, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Noble receive payments from pharmaceutical companies?
Yes. Dr. Noble received a total of $12,609 from 8 companies across 84 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Noble) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Reproductive Endocrinology Physicians in El Paso
Browse reproductive endocrinology physicians in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Reproductive Endocrinology Physicians in TX
Reproductive endocrinology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Reproductive Endocrinology Physicians in TX
Which TX reproductive endocrinology physicians receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
By company
TherapeuticsMD, Inc. Payments to Doctors
See all physicians who received payments from TherapeuticsMD, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →